mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.006 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.006 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.007 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.008 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.008 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.009 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.009 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.009 |